| D006976 |
Hypertension, Pulmonary |
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. |
Pulmonary Hypertension |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000070857 |
Walk Test |
A measure of endurance tests that show how far and fast an individual can walk without stopping within a certain period of time. |
6-Min Walk Test,Six-Minute Walk Test,6-Minute Walk Test,Endurance Shuttle Walk Test,Incremental Shuttle Walk Test,6 Min Walk Test,6 Minute Walk Test,6-Min Walk Tests,6-Minute Walk Tests,Six Minute Walk Test,Six-Minute Walk Tests,Test, 6-Min Walk,Test, 6-Minute Walk,Test, Six-Minute Walk,Test, Walk,Tests, 6-Min Walk,Tests, 6-Minute Walk,Tests, Six-Minute Walk,Tests, Walk,Walk Test, 6-Min,Walk Test, 6-Minute,Walk Test, Six-Minute,Walk Tests,Walk Tests, 6-Min,Walk Tests, 6-Minute,Walk Tests, Six-Minute |
|
| D012595 |
Scleroderma, Systemic |
A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. |
Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis |
|
| D015201 |
Meta-Analysis as Topic |
A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine. |
Clinical Trial Overviews,Data Pooling,Overviews, Clinical Trial,Clinical Trial Overview,Data Poolings,Meta Analysis as Topic,Overview, Clinical Trial |
|
| D017563 |
Lung Diseases, Interstitial |
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. |
Diffuse Parenchymal Lung Disease,Diffuse Parenchymal Lung Diseases,Interstitial Lung Disease,Interstitial Lung Diseases,Pneumonia, Interstitial,Pneumonitis, Interstitial,Interstitial Pneumonia,Interstitial Pneumonias,Interstitial Pneumonitides,Interstitial Pneumonitis,Lung Disease, Interstitial,Pneumonias, Interstitial,Pneumonitides, Interstitial |
|